According to the National Institute of Health, vareniciline or Chantix, a medication that helps patient to quit smoking, also has helped reduce alcohol consumption and alcohol cravings. “This is an encouraging development in our effort to expand and improve treatment options for people with alcohol dependence,” says Kenneth R. Warren, Ph.D., acting director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of NIH. “Current medications for alcohol dependence are effective for some, but not all, patients. New medications are needed to provide effective therapy to a broader spectrum of alcohol dependent individuals.”
Alcohol dependency is a serious problem in America. This chronic disease can include intense cravings, withdrawal symptoms that include vomiting, diarrhea and mood swings as well as loss of control when drinking. The study was conducted with both non-smokers and smokers alike and both groups felt the same results of wanting to drink less.
This smoking cessation medication suggests that it is actually effective in treating alcohol-related problems. During this study, the participants reported drinking an average of 28 drinks a week for women and 35 drinks per week for men. Results show a drop of almost 22% in both men and women after using the medication.
Another recent study by the Wheeler Center for the Neurobiology of Addiction saw a decrease by almost 35%.
Doctors suggest the medication may be a viable option for alcohol treatment facilities and drug rehab centers to use to help cut the cravings that recently-sober alcoholics feel. Although it hasn’t been approved by the FDA yet for this function, it’s seems that is where this medication is heading in the near future.